ÂÜÀòÂÒÂ×

The Research and Development team at ContraFect is responsible for advancing the company’s pipeline of therapeutic proteins and antibodies aimed at treating infectious diseases. This interdisciplinary team conducts innovative research, oversees preclinical and translational studies, and ensures the effective development and manufacturing processes for novel therapeutics, particularly targeting drug-resistant pathogens. They collaborate closely to translate scientific discoveries into viable clinical applications, ultimately aiming to improve patient outcomes in infectious disease management.